PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-05-06

Date Title Company
06-May-2021 Biocom California Strongly Opposes TRIPS Waiver Businesswire
06-May-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors Businesswire
06-May-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PureCycle Technologies, Inc. (PCT) on Behalf of Investors Businesswire
06-May-2021 iTeos to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 13, 2021 iTeos
06-May-2021 F-star Therapeutics, Inc. Announces Proposed Public Offering of Common Stock F-star Therapeutics
06-May-2021 Aptar Announces Price Increases Businesswire
06-May-2021 Cybin to Present at the Benzinga Global Small Cap Conference Businesswire
06-May-2021 Trinseo Reports First Quarter 2021 Financial Results Businesswire
06-May-2021 Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update Businesswire
06-May-2021 Exelixis Announces First Quarter 2021 Financial Results and Provides Corporate Update Businesswire
06-May-2021 Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results Businesswire
06-May-2021 Athersys Reports First Quarter 2021 Results Businesswire
06-May-2021 BeiGene Reports First Quarter 2021 Financial Results Businesswire
06-May-2021 McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results Businesswire
06-May-2021 NovaBay Pharmaceuticals Reports First Quarter 2021 Financial Results Businesswire
06-May-2021 Xeris Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021 Businesswire
06-May-2021 Puma Biotechnology Reports First Quarter 2021 Financial Results Businesswire
06-May-2021 Enanta Pharmaceuticals Reports Positive Data from Part 2 of its Phase 1b Study of EDP-514 in Chronic Hepatitis B Virus Patients on Treatment with a Nucleoside Reverse Transcriptase Inhibitor Businesswire
06-May-2021 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET Businesswire
06-May-2021 Celyad Oncology Announces First Quarter 2021 Financial Results and Recent Business Highlights Businesswire